<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00992004</url>
  </required_header>
  <id_info>
    <org_study_id>ARKOS</org_study_id>
    <secondary_id>2009-A00174-53</secondary_id>
    <nct_id>NCT00992004</nct_id>
  </id_info>
  <brief_title>Evaluation of the Efficacy of a Turmeric Extract (Arantal®) in Patients With Osteoarthritis of the Knee (Gonarthrosis).</brief_title>
  <official_title>Comparative, Randomized, Double-blind, Placebo-controlled, Parallel Group Study, to Evaluate the Efficacy of a Turmeric Extract (Arantal®) Versus Placebo in Patients With Osteoarthritis of the Knee (Gonarthrosis).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bioxtract SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nukleus</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Bioxtract SA</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy and the tolerance on 15 days of a
      turmeric extract (Arantal®) on pain related to gonarthrosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient's Assessment of Arthritis Pain using a Visual Analogue Scale (OA-Pain VAS)</measure>
    <time_frame>15 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Kinetics of the analgesic effect by a variance analysis in repeated measures (Likert Scale)</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>Arantal®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Highly bioavailable turmeric extract (food supplement)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Same capsule without the active ingredients (only excipients)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Arantal® (highly bioavailable turmeric extract)</intervention_name>
    <description>4 capsules a day, before breakfast</description>
    <arm_group_label>Arantal®</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is 40 through 80 years of age

          -  Subject diagnosed with femorotibial osteoarthritis of the knee (diagnosed according to
             the clinical and radiologic criteria of ACR),

          -  Patient's Assessment of Arthritis Pain measurement on the last 24 hours of at least 50
             mm on VAS,

          -  Patient has not received any NSAIDs within 72 hours and any analgesics within 24
             hours,

          -  Patients with chronic knee pain (i.e., knee pain at least every other day during the
             month preceding inclusion),

          -  Patients with radiologic knee osteoarthritis (Kellgren-Lawrence grade 2-4, on
             radiography less than 12 months old),

          -  Patients having signed the informed consent,

          -  Patients capable of comprehend the study instructions.

        Exclusion Criteria:

          -  Related to the osteoarthritis pathology:

               -  Osteoarthritis linked to a metabolic arthropathy: chondrocalcinosis already
                  diagnosed or defined by calcium edging on at least one femorotibial joint space,
                  gout...,

               -  Predominant associated symptomatic femoropatellar osteoarthritis,

               -  Chondromatosis or villonodular synovitis of the knee,

               -  Recent trauma (&lt; 1 month) of the knee responsible for the pain,

               -  Knee joint effusion justifying an evacuation through puncturing,

               -  Inflammatory flare (night pain, joint effusion) corresponding to a KOFUS score
                  less than 7,

               -  Pathology potentially interfering with the evaluation (metabolic inflammatory
                  arthropathy, rheumatoid arthritis, lower limb radiculalgia, arthritis...),

          -  Related to previous and associated treatments:

               -  Corticosteroids injection in the previous month, whatever the joint concerned,

               -  Hyaluronan injection in the evaluated knee during the previous 6 months,

               -  Patient who took NSAID in the 72 hours prior to inclusion or Analgesics in the 24
                  hours prior to inclusion,

               -  Slow-acting drugs for OA and/or dietary supplements taken within less than 3
                  months prior to the study product administration or for which the dose has been
                  modified in the last three months (ex: chondroitin sulfate, diacerein, soy and
                  avocado unsaponifiables, oxaceprol, granions de cuivre, glucosamine, phytotherapy
                  for OA, homeopathy for OA...),

               -  Anticoagulant treatment without gastric protection,

               -  General corticotherapy,

               -  Contraindication to paracetamol.

          -  Related to associated pathologies:

               -  Patient suffering from serious associated illness (liver failure, kidney failure,
                  non-controlled cardiovascular diseases...),

               -  Peptic ulcer.

          -  Related to patients:

               -  Pregnant or breastfeeding women

               -  Pre-menopausal women with no contraception

               -  Patients unable to write

               -  Patients enrolled in a clinical trial in the previous 3 months

               -  Patients under juristic protection or under guardianship.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves Henrotin, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Liege - Bone and Cartilage Research Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henri Mondor Hospital</name>
      <address>
        <city>Creteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2009</study_first_submitted>
  <study_first_submitted_qc>October 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2009</study_first_posted>
  <last_update_submitted>May 6, 2010</last_update_submitted>
  <last_update_submitted_qc>May 6, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr Ingrid Jacquemond-Collet</name_title>
    <organization>bioXtract SA</organization>
  </responsible_party>
  <keyword>Osteoarthritis, Knee</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>Joint Diseases</keyword>
  <keyword>Arthritis</keyword>
  <keyword>Rheumatic Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Turmeric extract</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

